Please Wait...

Financial Compliance

ClinPay Supports the Sunshine Act and Sarbanes-Oxley

We crafted our clinical trial management solutions to meet direct reporting needs in accordance with Sunshine Act requirements. We support mandated site invoicing, which satisfies several Sarbanes-Oxley related compliance concerns.

ClinPay maintains NPI numbers for both the principal investigator (PI) and the health care provider (HCP) that is receiving payment. This is critical as the proposed guidelines for reporting require payments made to an HCP (teaching hospitals) be reported as "direct" and payments associated with the PI also be reported as "indirect" as they are associated with the payment; however, they are not the direct recipient of the payment.

Additionally, PIs can change during the course of a study and ClinPay allows PIs, along with other team members, to be maintained with a start and stop date. The system will adjust the transactions to be associated with the applicable PI.

Our ClinPay solution has the ability to track NPI numbers by PI, HCP, or institution and can be configured to meet varying needs.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

Conducting Lymphoma ClinicalTrials? Lugano 2014 criteria for assessing FDG-PET/CT. An operational appch https://t.co/x5bdpI8jUI
bioclinica (52 minutes ago)
ICYMI: Clean Patient Optics: helping #ClinicalResearch teams meet or beat database lock. News https://t.co/pUem5e2cMG
bioclinica (1 hour ago)
Our Medical Imaging team is in the spotlight for a job well done! https://t.co/fkmt0zvPhf https://t.co/D7YMTeiSd3
bioclinica (2 days ago)
RT @melfass: "What this agreement means is that we can allocate scarce resources to areas of higher risk" @US_FDA on MRA with @EMA_News at…
bioclinica (3 days ago)
RT @DrugInfoAssn: What has been the biggest takeway for your organization so far? Tweet @ us using #DIA2017
bioclinica (5 days ago)
"Q" on #RBM & Total Quality Mgmt? @Kristin_Mauri has "A" @DrugInfoAssn #DIA2017 https://t.co/MqCxkmAfa0
bioclinica (5 days ago)

Latest Blogs: